DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo

5.51 0.21 (3.96%)

REAL-TIME: Last trade at

Extended Hours: $5.55 $0.04 (0.73%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

PGNX $5.51 3.96%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.30
Previous Close $5.30
Daily Range $5.27 - $5.52
52-Week Range $3.10 - $7.45
Market Cap $383.3M
P/E Ratio -8.69
Dividend (Yield) $0.00 (0.0%)
Volume 932,735
Average Daily Volume 1,015,776
Current FY EPS -$0.02





Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website:

News & Commentary

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

2nd Half Of 2014 Biotechnology Catalysts--Part 4

Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog

US Stock Futures Signal Higher Start On Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q2 2014 Results - Earnings Call Transcript

Progenics Pharmaceuticals (PGNX) Q2 2014 Results - Earnings Call Webcast

Earnings Scheduled For August 8, 2014

Will Progenics (PGNX) Disappoint this Earnings Season? - Analyst Blog

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

An Inefficient Stock Market Will Catch Up To Progenics

See More PGNX News...

PGNX's Top Competitors

PGNX $5.51 (3.96%)
Current stock: PGNX
AMGN $139.38 (0.50%)
Current stock: AMGN
GILD $107.56 (0.05%)
Current stock: GILD
BIIB $343.04 (0.53%)
Current stock: BIIB